India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
How does noise pollution affect the heart? Noise pollution is a problem that gradually harms health. Thousands of people lose their hearing every year due to noise pollution. The ear can only hear a certain intensity of sound. Loud noise damages the ears. There is a link between traffic noise and heart attacks. Traffic noise increases the risk of stroke, diabetes and many heart-related diseases. Loud noise is also considered a risk factor for heart disease. Due to excessive noise, people do not sleep at night and it also causes stress and restlessness. The number of heart patients has increased rapidly in the last few years. Especially young people are falling prey to heart attacks and noise pollution is also a major cause. A recent study published in the journal Circulation Research found a link between traffic noise and heart attacks. A team of international researchers has analyzed a large amount of data and found that traffic noise increases the risk of stroke, diabetes and ot...